OCULAR THERAPEUTIX, INC Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Ocular Therapeutix, Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2025.
  • Ocular Therapeutix, Inc Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2025 was $5.33M, a 6.32% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)

OCULAR THERAPEUTIX, INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $5.33M -$360K -6.32% Sep 30, 2025 10-Q 2025-11-04
Q2 2025 $5.88M -$122K -2.03% Jun 30, 2025 10-Q 2025-08-05
Q1 2025 $5.83M -$231K -3.81% Mar 31, 2025 10-Q 2025-05-05
Q4 2024 $5.95M -$527K -8.14% Dec 31, 2024 10-Q 2025-11-04
Q3 2024 $5.69M -$1.17M -17.1% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $6.01M -$1.25M -17.2% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $6.06M -$1.57M -20.5% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $6.47M -$1.57M -19.5% Dec 31, 2023 10-K 2025-03-03
Q3 2023 $6.87M +$2.86M +71.5% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $7.25M +$2.95M +68.5% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $7.63M +$3.03M +66.1% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $8.04M +$3.18M +65.2% Dec 31, 2022 10-K 2024-03-11
Q3 2022 $4M -$1.13M -21.9% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $4.31M -$1.07M -20% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $4.59M -$1.03M -18.2% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $4.87M -$977K -16.7% Dec 31, 2021 10-K 2023-03-06
Q3 2021 $5.13M -$933K -15.4% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $5.38M -$891K -14.2% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $5.62M -$850K -13.1% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $5.84M -$811K -12.2% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $6.06M -$774K -11.3% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $6.27M -$741K -10.6% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $6.47M +$1.31M +25.4% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $6.66M Dec 31, 2019 10-K 2021-03-11
Q3 2019 $6.84M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $7.01M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $5.16M Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.